UMIROLIMUS
UNII U36PGF65JH

Substance Identification & Data

This profile provides standardized clinical and technical data for Umirolimus, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U36PGF65JH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 851536-75-9 and the RxNorm Concept ID (RxCUI) 1942479. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

U36PGF65JH

CAS Registry Number

851536-75-9

RxNorm Concept ID

1942479

Detailed Substance Profile

Preferred Name

UMIROLIMUS

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

U36PGF65JH

The specific atomic composition represented as a molecular structure string.

InChIKey

C55H87NO14

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

YYSFXUWWPNHNAZ-PKJQJFMNSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C152800

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

11158972

Unique identification number in the NCBI database of chemical substances.

INN ID

9265

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-46

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O1C([C@]2(N(C(C([C@]3([C@@H](CC[C@@](C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C([C@@H]([C@@H](/C(=C/[C@H](C(C[C@H]1[C@@H](C[C@H]4C[C@H]([C@@H](CC4)OCCOCC)OC)C)=O)C)/C)O)OC)=O)C)C)/C)OC)(O3)[H])C)O)=O)=O)CCCC2)[H])=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Umirolimus. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.